Densitas® Selects CancerIQ to Power Lifetime Risk, Patient Adherence as Part of its Industry Leading Mammography Quality AI Platform
"Our collaboration with CancerIQ reflects our commitment to furnishing care providers with best-in-class solutions for breast health," said Mo Abdolell, founder and CEO, Densitas.
- "Our collaboration with CancerIQ reflects our commitment to furnishing care providers with best-in-class solutions for breast health," said Mo Abdolell, founder and CEO, Densitas.
- Densitas offers a robust AI-driven mammography quality assurance platform that comprises intelliMammo® and intelliMaven™.
- This integrated platform provides mammography facilities and clinical care teams with a comprehensive and scalable solution that boosts operational efficiency, improves mammography quality, and increases clinical confidence.
- Importantly, it ensures compliance with the FDA's Mammography Quality Standards Act (MQSA) EQUIP and the American College of Radiology's standards.